[go: up one dir, main page]

DK129434B - Process for the preparation of a pharmaceutical composition of acetylsalicylic acid as active substance as well as polysiloxane and a cellulose ether or ester and with gradual release of the active substance. - Google Patents

Process for the preparation of a pharmaceutical composition of acetylsalicylic acid as active substance as well as polysiloxane and a cellulose ether or ester and with gradual release of the active substance.

Info

Publication number
DK129434B
DK129434B DK487571AA DK487571A DK129434B DK 129434 B DK129434 B DK 129434B DK 487571A A DK487571A A DK 487571AA DK 487571 A DK487571 A DK 487571A DK 129434 B DK129434 B DK 129434B
Authority
DK
Denmark
Prior art keywords
active substance
polysiloxane
ester
preparation
pharmaceutical composition
Prior art date
Application number
DK487571AA
Other languages
Danish (da)
Other versions
DK129434C (en
Inventor
S Casadio
E Sclavi
R Perego
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of DK129434B publication Critical patent/DK129434B/en
Application granted granted Critical
Publication of DK129434C publication Critical patent/DK129434C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK487571AA 1970-10-09 1971-10-07 Process for the preparation of a pharmaceutical composition of acetylsalicylic acid as active substance as well as polysiloxane and a cellulose ether or ester and with gradual release of the active substance. DK129434B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK129434B true DK129434B (en) 1974-10-14
DK129434C DK129434C (en) 1975-03-10

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
DK487571AA DK129434B (en) 1970-10-09 1971-10-07 Process for the preparation of a pharmaceutical composition of acetylsalicylic acid as active substance as well as polysiloxane and a cellulose ether or ester and with gradual release of the active substance.

Country Status (8)

Country Link
US (1) US3853988A (en)
CA (1) CA974883A (en)
DE (1) DE2149699A1 (en)
DK (1) DK129434B (en)
ES (1) ES395533A1 (en)
FR (1) FR2110314B1 (en)
GB (1) GB1357737A (en)
SE (1) SE382560B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (en) * 1979-01-23 1980-08-07 Hoechst Ag DEPOT BODY BASED ON SILICONE RUBBER AND METHOD FOR THE PRODUCTION THEREOF
FR2514261B1 (en) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog NOVEL COMPOSITION FOR COATING FOODS AND DRUGS AND GRANULES THUS COATED
DE3508097A1 (en) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt COMBINATION PRODUCT MADE OF XANTHINE DERIVATIVES AND O-ACETYLSALICYL ACID OR THEIR PHARMACOLOGICALLY COMPATIBLE SALTS AND THE USE THEREOF
FR2653338B1 (en) * 1989-10-23 1994-06-10 Dow Corning Sa FORMULATION FOR SUSTAINED RELEASE DRUGS AND THE USE THEREOF.
CN1146154A (en) * 1994-03-18 1997-03-26 A·施米德特 Use of dimeticone in local antibacterial treatment and/or prevention and treatment of syndromes and infectious diseases related to helicobacter pylori (Hp)
DE4409357C2 (en) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Use of Dimeticon to eradicate Heliobacter pylori
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
WO2014014753A1 (en) 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
SE382560B (en) 1976-02-09
GB1357737A (en) 1974-06-26
DK129434C (en) 1975-03-10
FR2110314A1 (en) 1972-06-02
CA974883A (en) 1975-09-23
ES395533A1 (en) 1974-10-16
DE2149699A1 (en) 1972-04-13
FR2110314B1 (en) 1975-06-06
US3853988A (en) 1974-12-10

Similar Documents

Publication Publication Date Title
DK129446B (en) Analogous process for the preparation of phenoxyhydroxypropylamines or acid addition salts thereof.
DK124547B (en) Analogous process for the preparation of (3-amino-2-hydroxy-propyloxy) -thiochroman derivatives or acid addition salts thereof.
DK132303C (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORM WITH RETAINING EFFECT
DK146434C (en) PROCEDURE FOR THE PREPARATION OF TABLETS OR SUPPLIES WITH LONG-TERM RELEASE
DK131858B (en) Analogous process for the preparation of 4-amino-6-arylpyrimidine compounds or acid addition salts thereof.
DK129434B (en) Process for the preparation of a pharmaceutical composition of acetylsalicylic acid as active substance as well as polysiloxane and a cellulose ether or ester and with gradual release of the active substance.
DK128562B (en) Process for the preparation of basic esters of 3-methylflavone-8-carboxylic acid or acid addition salts of these esters.
DK129513B (en) Analogous process for the preparation of basic substituted alkylideneaminooxyalkylcarboxylic acid esters or acid addition salts thereof.
SE396010B (en) PROCEDURE FOR THE PREPARATION OF ACTIVE SUBSTANCE CONTAINING PREPARATIONS WITH LONG-TERM EFFECT IN THE FORM OF TABLETS, DRAGONS OR CAPSULES
NO144170C (en) PROCEDURE FOR THE PREPARATION OF DESACETOXY-CEPHALOSPORANIC ACID DERIVATIVES.
DK142984C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF BENZOBICYCLOAL CANAMIN OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS
DK139582B (en) Analogous process for the preparation of racemic or optically active benzocycloheptaisoquinoline compounds or acid addition salts thereof.
DK123806B (en) Process for the preparation of tablets or pills with slow release of an active substance.
DK131567C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF 3H-1,4-BENZODIAZEPINES OR ACID ADDITIONAL SALTS THEREOF
DK130958B (en) Analogous process for the preparation of racemic or optically active 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes or their physiologically acceptable acid addition salts.
DK129164B (en) Analogous process for the preparation of 3-alkyl-5-aryloxymethylisoxazoles or acid addition salts thereof.
DK122323B (en) Process for the preparation of 1-alkyl- (or alkenyl) -2-aminomethylpyrrolidines or acid addition salts thereof.
DK138490B (en) Process for the preparation of prostadienic acid derivatives.
DK134154B (en) Analogous process for the preparation of 5-cyclohexyl-1-indanecarboxylic acid derivatives.
DK130288B (en) Analogous process for the preparation of alkanolamine derivatives or acid addition salts thereof.
DK126424B (en) Analogous process for the preparation of esters of fluocinolone acetonide.
DK129993B (en) Analogous process for the preparation of indoacetic acid derivatives.
DK137834B (en) Analogous process for the preparation of triazolobenzodiazepine derivatives or acid addition salts thereof.
DK131623B (en) Process for the preparation of alpha-substituted 2-aminomethyl-benzyl alcohols or physiologically tolerable acid addition salts thereof.
DK125324B (en) Analogous process for the preparation of racemic or optically active sulfamoylpyrimidines.